With advanced standardization, automation, and scalability, Evoseps' new end-to-end proteomics workflow will revolutionize the field of proteomics. The new system will be modular and customizable, allowing for diverse applications and advancements in proteomics research.
Proteomics is crucial in identifying new biomarkers and therapeutic targets by unraveling complex biological systems. However, due to a lack of standardization, previous workflows were labor-intensive hindering advancements in the field. In a press release that can be found here, Evosep introduces a new workflow that by combining standardization and automation can help advance the field in a more cost-effective manner, while maintaining the highest level of data quality.
By implementing rigorous quality control measures and calibration protocols, researchers can confidently compare data and collaborate effectively, fostering advancements in the field of proteomics. Evosep also reports up to 100 times less protein needed when compared to other proteomics workflows, reducing costs and increasing the scalability of the process through increased efficiency.
"We are thrilled to introduce our End-to-End Proteomics Workflow, which addresses longstanding challenges in the field of proteomics research," said Ole Vorm, Founder and Chairman of Evosep. "By combining standardization and automation, we aim to empower researchers with an efficient and reliable solution that propels the discovery of novel biomarkers, therapeutic targets, and personalized medicine. Eventually the cost of proteomics will be dominated by the cost of the depreciation of the mass spectrometer, but this new reliable and highly productive workflow is an important step for the field in terms of cutting expenses and assuring productivity!